Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
Lifileucel for Uveal Melanoma
Recruiting1 awardPhase 1
West Harrison, New York
This trial is testing lifileucel, a treatment that uses a patient's own immune cells, in patients with advanced uveal melanoma. The treatment aims to boost the body's natural ability to fight cancer. Lifileucel has shown promising results in treating melanoma that does not respond to other treatments.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service